Avricore Health Inc. AVCR.V

Company Overview

Avricore Health Inc. is a Canadian health technology and diagnostics company focused on point-of-care testing, data connectivity, and pharmacy-based health screening solutions. The company operates primarily in the healthcare technology and diagnostic services industries, with a business model centered on delivering rapid screening systems that connect patients, pharmacies, and healthcare providers through real-time health data platforms. Its core revenue drivers have included diagnostic testing services, technology platform deployment, and commercialization partnerships tied to pharmacy networks and healthcare providers.

The company is best known for its HealthTab™ platform, which enables community pharmacies and healthcare locations to conduct point-of-care blood testing and health assessments using connected diagnostic devices. Avricore Health has positioned itself around decentralized healthcare delivery and preventative screening, particularly in chronic disease management and cardiovascular risk assessment. The company evolved from earlier healthcare technology and wellness initiatives into a diagnostics-focused platform business, expanding its pharmacy-centered testing model across Canada through strategic commercial relationships and technology integration initiatives.

Business Operations

Avricore Health conducts operations primarily through its diagnostic and health data connectivity activities, with HealthTab™ serving as its principal operating platform. The system integrates point-of-care analyzers, cloud-based reporting tools, and workflow software that allows pharmacists and healthcare professionals to perform rapid tests for conditions such as lipid disorders, diabetes indicators, and other cardiovascular-related metrics. Revenue generation has historically come from platform deployment, testing-related services, device utilization, and recurring health screening activities conducted through participating pharmacy networks.

The company’s operations are concentrated mainly in Canada, though its technology and diagnostic framework are structured to support broader healthcare deployment models. Avricore Health has collaborated with pharmacy operators, diagnostic technology providers, and healthcare stakeholders to expand access to community-based screening. Partnerships involving pharmacy chains and diagnostic equipment suppliers have been important to scaling its network. Public disclosures identify relationships tied to pharmacy-based implementation and healthcare technology integration, though some partnership scope details remain limited in publicly available filings.

Strategic Position & Investments

Avricore Health’s strategic direction has focused on expanding decentralized healthcare delivery through pharmacy-led diagnostics and connected health infrastructure. The company has emphasized growth through wider adoption of HealthTab™, increased testing volumes, and integration of diagnostic data into broader healthcare workflows. Management has consistently highlighted preventative care, chronic disease screening, and accessible community health services as core strategic priorities.

The company has also pursued investments in digital health capabilities and scalable diagnostic infrastructure intended to support population health initiatives and recurring healthcare engagement. Avricore Health’s strategy aligns with broader healthcare trends favoring localized testing, rapid diagnostics, and data-enabled care coordination. Publicly available information indicates continued emphasis on expanding pharmacy participation and leveraging connected diagnostic technologies, although some future commercialization outcomes remain dependent on adoption rates and healthcare market conditions.

Geographic Footprint

Avricore Health is headquartered in Canada, with operations and commercial activities primarily concentrated in the Canadian healthcare market. Its diagnostic platform deployments have focused on community pharmacies and healthcare locations across multiple Canadian provinces. The company’s market presence is strongest within the Canadian pharmacy and preventative care ecosystem, where regulatory structures and pharmacy accessibility support point-of-care testing initiatives.

While the company does not currently maintain the same international scale as larger healthcare technology firms, its platform model and diagnostic connectivity framework are designed for broader applicability. Public disclosures indicate strategic interest in scalable healthcare delivery systems that could support future expansion opportunities. Data regarding significant direct operational presence outside Canada is inconclusive based on available public sources.

Leadership & Governance

Avricore Health’s leadership team has emphasized healthcare accessibility, preventative diagnostics, and technology-enabled pharmacy services as central elements of the company’s vision. Governance and operational strategy have focused on building commercial healthcare partnerships while expanding the adoption of connected diagnostic screening systems in community settings.

Key executives and leadership figures publicly associated with the company include:

• Hector Bremner – Chief Executive Officer
• Paul Finkelstein – Director
• Mark van der Horst – Chief Financial Officer

The company’s leadership approach has centered on integrating diagnostics into frontline healthcare environments and positioning pharmacies as accessible health assessment hubs. Strategic communications and corporate filings have consistently highlighted scalability, preventative care engagement, and digital health connectivity as major operational themes.